Literature DB >> 18606654

FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.

Cristiano Scottà1, Marzia Soligo, Cristina Camperio, Enza Piccolella.   

Abstract

Among the signals necessary to generate CD4(+)CD25(+)FOXP3(+) T cells from CD4(+)CD25(-)FOXP3(-) T cells, a pivotal role is played by CD28. However, in humans, it is not known whether CD28 signaling independently of TCR promotes forkhead box protein 3 (FOXP3) expression and regulates CD4(+)CD25(+)FOXP3(+) T cell functions. To address this issue, starting from our previous experience, we analyzed the unique signals delivered by CD28 following stimulation by its natural ligand B7. Our results show that, in primary CD4(+)CD25(-) T cells, CD28 signals independent of TCR-mediated stimulatory pathways are sufficient to induce the transcription of FOXP3 in a small number of CD4(+)CD25(-) T cells committed to express FOXP3. These signals are dependent on CD28-derived PI3K/Akt pathways and resistant to cyclosporin A. In addition, we demonstrated that translated FOXP3 was recruited to CD25, Il-2, and Ctla4 target promoters. CD28-mediated FOXP3 expression was transient and correlated with CD25 expression. The presence of FOXP3 in CD28-activated CD4(+)CD25(-) T cells correlated with a transient unresponsiveness to antigenic stimuli. The addition of exogenous IL-2 did not influence either FOXP3 or CD25 expression but rescued CD28-activated T cells from apoptosis. Our results, demonstrating that FOXP3 expression driven solely by the CD28/B7 interaction inhibited T cell activation, support the role of CD28 in the regulation of peripheral tolerance and suggest a new mechanism through which it could occur.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606654     DOI: 10.4049/jimmunol.181.2.1025

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.

Authors:  Michelle M Collazo; Kim H T Paraiso; Mi-Young Park; Amy L Hazen; William G Kerr
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

2.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

3.  A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.

Authors:  Andrea Vergani; Francesca D'Addio; Mollie Jurewicz; Alessandra Petrelli; Toshihiko Watanabe; Kaifeng Liu; Kenneth Law; Christian Schuetz; Michele Carvello; Elena Orsenigo; Shaoping Deng; Scott J Rodig; Javeed M Ansari; Carlo Staudacher; Reza Abdi; John Williams; James Markmann; Mark Atkinson; Mohamed H Sayegh; Paolo Fiorina
Journal:  Diabetes       Date:  2010-09       Impact factor: 9.461

Review 4.  The role of tregs in glioma-mediated immunosuppression: potential target for intervention.

Authors:  William Humphries; Jun Wei; John H Sampson; Amy B Heimberger
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

5.  Forkhead transcription factor FOXP3 upregulates CD25 expression through cooperation with RelA/NF-κB.

Authors:  Cristina Camperio; Silvana Caristi; Giorgia Fanelli; Marzia Soligo; Paola Del Porto; Enza Piccolella
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

Review 6.  Mechanisms underlying the induction of regulatory T cells and its relevance in the adaptive immune response in parasitic infections.

Authors:  Laura Adalid-Peralta; Gladis Fragoso; Agnes Fleury; Edda Sciutto
Journal:  Int J Biol Sci       Date:  2011-11-01       Impact factor: 6.580

7.  Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals.

Authors:  Evaggelia Liaskou; Louisa Jeffery; Dimitrios Chanouzas; Blagoje Soskic; Michael F Seldin; Lorraine Harper; David Sansom; Gideon M Hirschfield
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

8.  Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling.

Authors:  Amber Emmerson; Silvia Cellone Trevelin; Heloise Mongue-Din; Pablo D Becker; Carla Ortiz; Lesley A Smyth; Qi Peng; Raul Elgueta; Greta Sawyer; Aleksandar Ivetic; Robert I Lechler; Giovanna Lombardi; Ajay M Shah
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

9.  Expansion of human regulatory T-cells from patients with type 1 diabetes.

Authors:  Amy L Putnam; Todd M Brusko; Michael R Lee; Weihong Liu; Gregory L Szot; Taumoha Ghosh; Mark A Atkinson; Jeffrey A Bluestone
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

10.  A non-conserved amino acid variant regulates differential signalling between human and mouse CD28.

Authors:  Nicla Porciello; Paola Grazioli; Antonio F Campese; Martina Kunkl; Silvana Caristi; Marta Mastrogiovanni; Michela Muscolini; Francesca Spadaro; Cédric Favre; Jacques A Nunès; Aldo Borroto; Balbino Alarcon; Isabella Screpanti; Loretta Tuosto
Journal:  Nat Commun       Date:  2018-03-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.